Progression of Renal Disease: Renoprotective Specificity of Renin-Angiotensin System Blockade

Recent guidelines for management of patients with chronic kidney disease recommend both lower optimal BP targets and agents that block the renin-angiotensin system (RAS) for specific additional BP-independent renoprotection. Although there are other compelling rationales to use RAS blockade in patie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical journal of the American Society of Nephrology 2006-09, Vol.1 (5), p.1054-1065
Hauptverfasser:	Griffin, Karen A, Bidani, Anil K
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiotensin II Type 1 Receptor Blockers - pharmacology Angiotensin II Type 1 Receptor Blockers - therapeutic use Angiotensin-Converting Enzyme Inhibitors - pharmacology Angiotensin-Converting Enzyme Inhibitors - therapeutic use Animals Antihypertensive Agents - pharmacology Antihypertensive Agents - therapeutic use Blood Pressure - drug effects Chronic Disease Disease Progression Humans Hypertension - complications Hypertension - drug therapy Hypertension - physiopathology Kidney Diseases - complications Kidney Diseases - drug therapy Kidney Diseases - etiology Kidney Diseases - physiopathology Kidney Failure, Chronic - etiology Kidney Failure, Chronic - physiopathology Kidney Failure, Chronic - prevention & control Practice Guidelines as Topic Renin-Angiotensin System - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!